Phibro Animal Health Corp (PAHC) Position Increased by Algert Global LLC

Algert Global LLC boosted its stake in Phibro Animal Health Corp (NASDAQ:PAHC) by 37.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 28,385 shares of the company’s stock after buying an additional 7,800 shares during the period. Algert Global LLC’s holdings in Phibro Animal Health were worth $1,218,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of PAHC. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health during the third quarter worth $115,000. Royal Bank of Canada raised its holdings in shares of Phibro Animal Health by 2,104.6% during the first quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock worth $151,000 after purchasing an additional 3,641 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new stake in shares of Phibro Animal Health during the third quarter worth $206,000. Piedmont Investment Advisors LLC acquired a new stake in shares of Phibro Animal Health during the second quarter worth $213,000. Finally, Janus Henderson Group PLC acquired a new stake in shares of Phibro Animal Health during the second quarter worth $222,000. 49.63% of the stock is currently owned by hedge funds and other institutional investors.

PAHC has been the topic of a number of research reports. BidaskClub cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, August 16th. Morgan Stanley increased their target price on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a report on Wednesday, August 29th. Zacks Investment Research cut shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Wednesday, August 29th. Finally, ValuEngine cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Monday, November 12th. Three equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. Phibro Animal Health currently has an average rating of “Hold” and an average price target of $43.50.

Shares of NASDAQ:PAHC opened at $32.87 on Friday. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 19.06, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77. Phibro Animal Health Corp has a 1-year low of $32.02 and a 1-year high of $54.62. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.82 and a current ratio of 3.26.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.03). The business had revenue of $200.20 million for the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a return on equity of 38.91% and a net margin of 7.89%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period last year, the company posted $0.38 earnings per share. As a group, equities research analysts anticipate that Phibro Animal Health Corp will post 1.72 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.46%. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date of this dividend is Tuesday, November 27th. Phibro Animal Health’s dividend payout ratio is 27.59%.

In other news, VP Daniel M. Bendheim sold 2,500 shares of the company’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the completion of the transaction, the vice president now owns 2,500 shares in the company, valued at $110,750. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $42.84, for a total transaction of $428,400.00. Following the transaction, the insider now owns 10,000 shares of the company’s stock, valued at approximately $428,400. The disclosure for this sale can be found here. Insiders have sold 13,020 shares of company stock valued at $562,571 in the last 90 days. Insiders own 50.29% of the company’s stock.

WARNING: This report was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/12/08/phibro-animal-health-corp-pahc-position-increased-by-algert-global-llc.html.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Article: Swap

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply